Fapon showcases its total IVD solutions at Hospital Expo to empower local Indonesian IVD industry

October 15, 2024 07:28 PM AEDT | By Cision

Fapon showcases its total IVD solutions at Hospital Expo to empower local Indonesian IVD industry — Image source: Kalkine Media

Recent News

Xinhua Silk Road: Time-travel micro-drama shows charm of E. China's Ni...

IFS and Sovos announce technology partnership to transform tax complia...

Coty shares fall after warning as US market slows

Travelers Are Spending Big This Holiday Season-With Higher Expectation...

DONGGUAN, China, Oct. 15, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is excited to participate in the Hospital Expo in Jakarta, Indonesia, from October 16 – 19. Fapon will showcase its total IVD solutions, including IVD raw materials, reagent services and open-system instruments, all designed to support and empower local Indonesian IVD industry.

At the exhibition, Fapon will present a suite of total solutions across various applications, including CLIA, PCR, and POCT. We will also showcase our extensive portfolio of high-performance raw materials and reagent services for diagnostic testing, such as HIV, TP, TB, and dengue. Leveraging its solid foundation in IVD technology, Fapon integrates raw materials, reagent services, and open instrument platforms into total solutions. This approach ensures a reliable, versatile, and seamless services for our local IVD partners, addressing their diverse diagnostic challenges.

In addition, Fapon is highlighting its open-system instruments, including the Shine i1000, Shine i3000 and Shine i6000 open-system CLIA analyzers for low- to high-throughput testing, and the Ideal 30/60 and Nous 30V fully automated molecular diagnostic systems, along with immunofluorescence POCT analyzers. These open-system instruments exemplify Fapon's dedication to providing advanced diagnostic technologies that cater to the specific requirements of the local IVD industry.

In order to further support local IVD partners, Fapon has established a state-of-the-art manufacturing facility in Jawa Barat. Constructed in adherence to the stringent ISO 14644 standards, this facility has set a new benchmark for IVD production in Indonesia. With this world-class facility, Fapon aims to leverage its leading IVD technologies and expertise to empower the development of Indonesia's diagnostic capabilities.

Looking ahead, Fapon is committed to deepening its presence in the Indonesian market, strengthening collaborations with local partners and empowering the localization of the IVD industry in the country.

About Fapon

Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy. Integrating a one-stop solution on raw materials, reagents and innovative open instrument platforms, the Company has grown into a leading supplier in in-vitro diagnostics. Fapon boasts advanced innovations in therapeutics technologies and AI algorithm platforms with data insights that contribute to a better and healthier world. Supported by its strong global R&D, manufacturing, sales and service network, Fapon's products have established presence in 68 countries and regions, serving more than 2,500 business partners worldwide.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.